09:56 AM EST - IntelGenx Corp. : Announced the USPTO (United States Patent and Trademark Office) has granted a patent protecting Rizaport™, an oral thin film formulation of rizatriptan benzoate for the treatment of acute migraines. This patent protects the composition of Rizaport™ and will be listed in the Orange Book upon approval of the product by the FDA. IntelGenx Corp.
shares V.IGX are trading unchanged at $0.68.
